Once free, drug for rare disease now being sold for $375K a year02:02
Thanks to a law designed to encourage drug development for rare diseases, Catalyst Pharmaceuticals can now sell the treatment exclusively for seven years -- and has set the price for it at $375,000 on average, when it used to be given to patients for free by a smaller drug company.
American companies being targeted by renewed cyber attacks from China and Iran01:11
Navy veteran identified as ‘kissing sailor’ in WWII photo dies at 9501:20
Man rescued from quicksand inside Zion National Park01:01
American and British ISIS brides plead to return home01:16
Five best friends elected to Colorado’s State Senate02:00
Ukraine military forces preparing for potential showdown at sea with Russia01:14